SEC Tracker
Get the app

Sionna Therapeutics SION

OrbiMed Private Investments VIII (Shareholder) plans to sell 210,876 SION shares, about $9M

Form
144/A
Filed
Importance
Routine
  1. Approximate sale date: May 29, 2026
  2. Broker: TD Cowen
  3. Shares acquired by: IPO
  4. 10b5-1 plan adopted: Feb 10, 2025

All of OrbiMed Private Investments VIII's insider filings, holdings and planned sales

Written from the Form 144/A on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Sionna Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Emergent BioSolutions EBS public float $343M, Jun 30, 2025
  2. Northwest Biotherapeutics NWBO public float $340M, Jun 30, 2025
  3. Amarin AMRN public float $335M, Jun 30, 2025
  4. Rigel Pharmaceuticals RIGL public float $332M, Jun 30, 2025
  5. Usana Health Sciences USNA public float $328M, Jun 27, 2025